首页> 外文期刊>Vaccine >CD4(+) T-cells, gamma delta T-cells and B-cells are associated with lack of vaccine protection in Mycobacterium avium subspecies paratuberculosis infection
【24h】

CD4(+) T-cells, gamma delta T-cells and B-cells are associated with lack of vaccine protection in Mycobacterium avium subspecies paratuberculosis infection

机译:CD4(+)T细胞,γδT细胞和B细胞与鸟分枝杆菌亚种副结核病感染中缺乏疫苗保护相关

获取原文
获取原文并翻译 | 示例
           

摘要

Vaccination is one of the strategies used to control the spread of Mycobacterium avium subspecies paratuberculosis (MAP) infection in livestock. Gudair (R) is a widely-used vaccine in sheep and goats and is the only vaccine approved for use in sheep in Australia and New Zealand. This vaccine reduces mortality due to MAP-infection by up to 90% but some sheep remain infectious by shedding MAP in faeces, despite vaccination. In this study, using an experimental infection model in sheep, our aim was to assess differences in immune parameters between vaccinated MAP-exposed sheep in which the vaccine was effective compared to those in which it failed to protect against infection. We assessed immune parameters such as MAP-specific IFN gamma, IL-10 and lymphocyte proliferative responses and serum antibody levels. At the end of the trial, 72% of non-vaccinated sheep and 24% of vaccinated sheep were infected, as defined by the detection of viable MAP in intestinal tissues when the trial was terminated at 49 weeks post exposure. There were significant differences in the proliferation of CD4(+), B and gamma delta T-cells over time in vaccinated sheep in which the vaccine failed to protect against infection compared to the non-infected vaccinated sheep. There were no significant differences in the IFN gamma response or serum antibody levels between the vaccinated infected and vaccinated non-infected sheep. These results emphasise the importance of specific lymphocyte subsets in protecting against MAP-infection, especially in vaccinated sheep, and that immune parameters other than the commonly used IFN gamma and antibody tests are required when assessing vaccine efficacy. (C) 2014 Elsevier Ltd. All rights reserved.
机译:疫苗接种是用于控制家畜中鸟分枝杆菌亚种副结核病(MAP)感染传播的策略之一。 Gudair(R)是在绵羊和山羊中广泛使用的疫苗,并且是澳大利亚和新西兰唯一批准用于绵羊的疫苗。这种疫苗可将因MAP感染而导致的死亡率降低多达90%,但尽管有疫苗接种,但一些绵羊仍通过在粪便中排出MAP保持感染力。在这项研究中,使用实验性绵羊感染模型,我们的目的是评估在接种MAP疫苗的绵羊中,有效疫苗与不能预防感染的绵羊之间的免疫参数差异。我们评估了免疫参数,例如MAP特异性IFNγ,IL-10和淋巴细胞的增殖反应以及血清抗体水平。在试验结束时,有72%的未免疫绵羊和24%的免疫绵羊被感染,这是根据暴露后49周试验终止后在肠道组织中检测到存活的MAP定义的。随着时间的推移,接种疫苗的绵羊中CD4(+),B和伽马三角洲T细胞的增殖存在显着差异,其中与未感染的接种绵羊相比,疫苗无法预防感染。接种疫苗的和未接种疫苗的绵羊之间的IFNγ反应或血清抗体水平无显着差异。这些结果强调了特定淋巴细胞亚群在预防MAP感染(特别是在接种疫苗的绵羊中)中的重要性,并且在评估疫苗效力时,除了常用的IFNγ和抗体测试,还需要其他免疫参数。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号